
Please try another search
TOKYO (Reuters) - Japan's Shionogi & Co (T:4507), creator of the blockbuster cholesterol treatment Crestor, said on Monday it would tie up with Ping An Insurance Group Co of China (SS:601318), selling a 2.05% voting stake for 33.53 billion yen ($311 million).
Shionogi will form a joint venture with the Chinese group's unit, Ping An Life Insurance of China Ltd, with the aim of discovering and distributing new drugs and developing generic ones as it looks to expand in China, it said in a statement.
"To attain our growth strategy beyond 2020, we must realize the expansion of our business in China, which is expected to show the greatest pharmaceutical market growth in the world over the next 10 years," Shionogi said in the statement.
Shionogi, which gains roughly half its revenue from royalties, posted four-straight years of record operating profit through 2019. It focuses on infectious diseases but a looming patent cliff for its HIV treatments will create an earnings gap that will be hard to completely offset.
Ping An Insurance Group, China's largest insurer by market value, said in February it expected the coronavirus outbreak to affect its business in the first half.
The group's Good Doctor (HK:1833) subsidiary is ramping up its online doctor consultation business in Asia as the virus spread spurs demand. Japans' SoftBank Group (T:9984) has invested in Good Doctor and the two formed a healthcare joint venture last year.
Shionogi's shares rose 2.8% in Tokyo trading before the announcement, versus a 1.6% drop in the broader market.
PARIS (Reuters) - French company TotalEnergies said it had agreed to buy 50% of Clearway Energy (NYSE:CWENa) Group, the fifth-largest renewables company in the United States,...
TOKYO (Reuters) - Japan Investment Corp (JIC) is considering the acquisition of Toshiba (OTC:TOSYY) Corp, Bloomberg reported on Wednesday citing an unnamed source. Bain Capital...
By Kanupriya Kapoor (Reuters) - Asia stocks opened mostly in positive territory on Wednesday even as global growth concerns and weak U.S. economic data weighed on Wall Street...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.